|
ZNF562 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.97510000005319E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.418490E-04 |
| Normal-vs-Stage2 |
5.177700E-03 |
| Normal-vs-Stage3 |
4.86830000001603E-06 |
| Normal-vs-Stage4 |
3.56239999999008E-06 |
| Stage1-vs-Stage2 |
8.491200E-01 |
| Stage1-vs-Stage3 |
2.043200E-01 |
| Stage1-vs-Stage4 |
4.708500E-02 |
| Stage2-vs-Stage3 |
2.779000E-01 |
| Stage2-vs-Stage4 |
1.029640E-01 |
| Stage3-vs-Stage4 |
4.616000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.58999999999576E-05 |
| Normal-vs-AfricanAmerican |
2.585600E-02 |
| Normal-vs-Asian |
8.157900E-04 |
| Caucasian-vs-AfricanAmerican |
5.714800E-01 |
| Caucasian-vs-Asian |
8.408800E-01 |
| AfricanAmerican-vs-Asian |
5.233800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.04289999999885E-05 |
| Normal-vs-Female |
2.32329999999559E-05 |
| Male-vs-Female |
3.976200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.058520E-03 |
| Normal-vs-Age(41-60Yrs) |
6.28000000002515E-07 |
| Normal-vs-Age(61-80Yrs) |
1.431430E-04 |
| Normal-vs-Age(81-100Yrs) |
1.532130E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.622500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.122000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.839400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.485200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.614000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.830600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.342400E-02 |
| Classical-VS-Follicular |
7.022300E-02 |
| Classical-VS-Other |
9.788300E-02 |
| Classical-VS-Normal |
3.385700E-04 |
| Tall-VS-Follicular |
5.816800E-01 |
| Tall-VS-Other |
4.864600E-01 |
| Tall-VS-Normal |
3.191300E-04 |
| Follicular-VS-Other |
3.157200E-01 |
| Follicular-VS-Normal |
4.24770000000407E-05 |
| Other-VS-Normal |
5.719200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.89550000000627E-05 |
| Normal-vs-N1 |
2.66159999995352E-06 |
| N0-vs-N1 |
1.230990E-01 |
|
|
